These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11203011)

  • 1. Bladder cancer mortality with aging: male/female comparison with autocorrelation and time frame shift.
    Spencer RP
    J Nutr Health Aging; 1999; 3(3):186. PubMed ID: 11203011
    [No Abstract]   [Full Text] [Related]  

  • 2. Bladder cancer mortality in the United States, 1951-1989: increased environmental carcinogenesis in men.
    Riggs JE
    Regul Toxicol Pharmacol; 1994 Oct; 20(2):187-97. PubMed ID: 7846305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of urinary bladder cancer: international variation in mortality.
    Ohno Y; Aoki K
    Nagoya J Med Sci; 1980 Nov; 43(1-2):41-64. PubMed ID: 7254311
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program.
    Konety BR; Joslyn SA
    J Urol; 2003 Nov; 170(5):1765-71. PubMed ID: 14532772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related risk of mortality from bladder cancer in diabetic patients: a 12-year follow-up of a national cohort in Taiwan.
    Tseng CH; Chong CK; Tseng CP; Chan TT
    Ann Med; 2009; 41(5):371-9. PubMed ID: 19191082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older.
    Hollenbeck BK; Miller DC; Taub D; Dunn RL; Underwood W; Montie JE; Wei JT
    Urology; 2004 Aug; 64(2):292-7. PubMed ID: 15302481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender, racial and age differences in bladder cancer incidence and mortality.
    Madeb R; Messing EM
    Urol Oncol; 2004; 22(2):86-92. PubMed ID: 15082003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characteristics and survival outcome of arsenic related bladder cancer in taiwan.
    Chen CH; Chiou HY; Hsueh YM; Chen CJ; Yu HJ; Pu YS
    J Urol; 2009 Feb; 181(2):547-52; discussion 553. PubMed ID: 19084863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bladder cancer survivals in New South Wales, Australia: why do women have poorer survival than men?
    Tracey E; Roder D; Luke C; Bishop J
    BJU Int; 2009 Aug; 104(4):498-504. PubMed ID: 19338538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. StatBite: A look at bladder cancer in the United States.
    J Natl Cancer Inst; 2009 Nov; 101(22):1533. PubMed ID: 19880811
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment delay and prognosis in invasive bladder cancer.
    Liedberg F; Anderson H; Månsson W
    J Urol; 2005 Nov; 174(5):1777-81; discussion 1781. PubMed ID: 16217282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of urinary bladder cancer in Oklahoma.
    Asal NR; Ferguson SW
    J Okla State Med Assoc; 1972 Oct; 65(10):409-17. PubMed ID: 5077205
    [No Abstract]   [Full Text] [Related]  

  • 14. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water.
    Marshall G; Ferreccio C; Yuan Y; Bates MN; Steinmaus C; Selvin S; Liaw J; Smith AH
    J Natl Cancer Inst; 2007 Jun; 99(12):920-8. PubMed ID: 17565158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians?
    Chamie K; Hu B; Devere White RW; Ellison LM
    BJU Int; 2008 Aug; 102(3):284-90. PubMed ID: 18410437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical cystectomy in the elderly: Comparison of survival between younger and older patients.
    Clark PE; Stein JP; Groshen SG; Cai J; Miranda G; Lieskovsky G; Skinner DG
    Cancer; 2005 Feb; 103(3):546-52. PubMed ID: 15630702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bladder cancer: a 26-year review.
    Cox CE; Cass AS; Boyce WH
    Trans Am Assoc Genitourin Surg; 1968; 60():22-30. PubMed ID: 5746140
    [No Abstract]   [Full Text] [Related]  

  • 18. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
    Mills RD; Turner WH; Fleischmann A; Markwalder R; Thalmann GN; Studer UE
    J Urol; 2001 Jul; 166(1):19-23. PubMed ID: 11435814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of advanced age in patients with bladder cancer treated with radical cystectomy.
    Resorlu B; Beduk Y; Baltaci S; Ergun G; Talas H
    BJU Int; 2009 Feb; 103(4):480-3. PubMed ID: 18990160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder.
    Wright JL; Porter MP; Li CI; Lange PH; Lin DW
    Cancer; 2006 Aug; 107(4):721-8. PubMed ID: 16826584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.